These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibition of delayed hypersensitivity reactions by a new agent, cis-1-methyl-4-isohexylcyclohexane carboxylic acid (IG-10)--II. The mechanism regarding the action on lymphokines. Nakatomi I; Nakamura K; Furukawa K; Koda A Int J Immunopharmacol; 1987; 9(2):243-53. PubMed ID: 3034812 [TBL] [Abstract][Full Text] [Related]
7. Antibodies to guinea pig lymphokines. II. Suppression of delayed hypersensitivity reactions by a "second generation" goat antibody against guinea pig lymphokines. Geczy CL; Geczy AF; De Weck AL J Immunol; 1976 Jul; 117(1):66-72. PubMed ID: 1084371 [TBL] [Abstract][Full Text] [Related]
8. Antigen-enhanced glucosamine incorporation by peritoneal macrophages in cell-mediated hypersensitivity. I. Studies on biology and mechanism. Hammond ME; Selvaggio SS; Dvorak HF J Immunol; 1975 Oct; 115(4):914-21. PubMed ID: 1100724 [TBL] [Abstract][Full Text] [Related]
9. Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes. Rocklin RE J Clin Invest; 1976 Apr; 57(4):1051-8. PubMed ID: 59738 [TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of suppression of delayed hypersensitivity by the antischistosomal compund niridazole. Daniels JC; Warren KS; David JR J Immunol; 1975 Nov; 115(5):1414-21. PubMed ID: 51891 [TBL] [Abstract][Full Text] [Related]
11. Role of lymphokines in regulation of macrophage differentiation. Onozaki K; Akagawa KS; Haga S; Miura K; Hashimoto T; Tokunaga T Cell Immunol; 1983 Feb; 76(1):129-36. PubMed ID: 6339080 [TBL] [Abstract][Full Text] [Related]
12. Lymphokines in sensitized rats. I. Migration inhibitory factor(s) from specifically stimulated thymocytes in vitro. Bakker WW; Engelhart JJ; Mulder I; Hoedemaeker PJ Int Arch Allergy Appl Immunol; 1975; 49(4):491-503. PubMed ID: 1099009 [TBL] [Abstract][Full Text] [Related]
13. Production of an antibody against guinea pig MIF. III. Biological activity of MIF recovered from immunoadsorbent column chromatography. Onozaki K; Haga S; Ichikawa M; Homma Y; Miura K; Hashimoto T Cell Immunol; 1981 Jun; 61(1):165-75. PubMed ID: 7020954 [No Abstract] [Full Text] [Related]
14. Inhibition of delayed hypersensitivity reactions by a new agent, cis-1-methyl-4-isohexylcyclohexane carboxylic acid (IG-10). Koda A; Nakatomi I; Nakamura K; Inoue H; Kamimura T Int J Immunopharmacol; 1985; 7(1):41-9. PubMed ID: 2860077 [TBL] [Abstract][Full Text] [Related]
15. Biological control of lymphokine function. Yoshida T; Cohen S Fed Proc; 1982 Jun; 41(8):2480-3. PubMed ID: 7044831 [TBL] [Abstract][Full Text] [Related]
16. Antibodies to guinea pig lymphokines. III. Reactions with radiolabeled lymphocyte activation products. Sorg C; Geczy CL Eur J Immunol; 1976 Oct; 6(10):688-93. PubMed ID: 797284 [TBL] [Abstract][Full Text] [Related]
17. Lymphokines. II. Use of horse monocytes as indicator cells for human MIF. Friedrich W; Lazary S; de Weck AL Int Arch Allergy Appl Immunol; 1976; 50(2):142-54. PubMed ID: 1107231 [TBL] [Abstract][Full Text] [Related]